Physician profile
Jack W Brunson
NPI 1316918253
$5,795.92
in general payments reported to CMS, 2019-2025
19 companies · $817 in 2025
The $817 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $607 · 2020: $740 · 2021: $1,163 · 2022: $810 · 2023: $545 · 2024: $1,115 · 2025: $817.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,477.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,195.59 | 2019-2025 | Vraylar, Qulipta, Ubrelvy |
| Astrazeneca Pharmaceuticals LP | $1,103.16 | 2019-2025 | Airsupra, Farxiga |
| Novo Nordisk INC | $813.06 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $286.68 | 2019-2022 | |
| Allergan, INC. | $282.36 | 2019-2020 | |
| Lilly USA, LLC | $212.04 | 2020-2025 | Mounjaro, Jardiance |
| Pfizer INC. | $182.88 | 2019-2021 | |
| Amgen INC. | $174.50 | 2020-2025 | Otezla, Repatha, Repatha |
| Axsome Therapeutics, INC. | $121.84 | 2023 | Auvelity |
| Sumitomo Pharma America, INC. | $94.37 | 2024 | Gemtesa |
| Exact Sciences Corporation | $66.09 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Medtronic, INC. | $51.49 | 2025 | Intellis Adaptivestim |
| Novartis Pharmaceuticals Corporation | $51.15 | 2024 | |
| Dexcom, INC. | $48.74 | 2023-2024 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $33.87 | 2023 | Veozah |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $31.84 | 2023-2025 | Trintellix |
| Daiichi Sankyo INC. | $20.29 | 2024 | Injectafer |
| Shield Therapeutics INC | $13.18 | 2024 | |
| Gt Medical Technologies, INC | $12.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jack Brunson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.